We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 09, 2016

Muscle Mass Loss During Chemotherapy Predicts Decreased Survival in Metastatic Colorectal Cancer

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer
J. Clin. Oncol 2016 Feb 22;[EPub Ahead of Print], S Blauwhoff-Buskermolen, KS Versteeg, MA de van der Schueren, NR den Braver, J Berkhof, JA Langius, HM Verheul

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading